Benefits of GLP-1 Peptide Therapy for Weight Loss Scientific studies have demonstrated that GLP-1 peptide therapy can lead to significant weight loss, with patients often losing between 5% to 15% of their body weight over a year
Unlike Wegovy, Zepbound, Ozempic, Mounjaro, and Foundayo, eloralintide does not act on the GLP-1, GIP, or glucagon receptors
The progression from one receptor (semaglutide) to two (tirzepatide) to three (retatrutide) follows a clear pattern of increasing efficacy
As cells become more responsive to insulin, the pancreas does not need to produce as much to maintain glucose control
We believe in tailoring each journey to your unique needs, and semaglutide is crucial in this customization